Concepedia

Author

Karen Sielaff

University of Wisconsin–Madison

Also Known As

K M Sielaff, K Sielaff, K. M. Sielaff, K.M. Sielaff, KAREN M. SIELAFF, Karen Sielaff

17

Publications

443

Citations

9

H-Index

39

Concepts

All Affiliations

University of Wisconsin–Madison
KS

About

Karen Sielaff is an author at University of Wisconsin–Madison specializing in medicine, immunology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

252

2

Immunology

4

4

206

3

Health Sciences

2

2

78

4

Engineering

1

1

60

5

Allergy

1

1

76

Karen Sielaff

×

9

Publications

430

Citations

9

H-Index

YearCitations

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Skin Cancer Prevention Study of α-Difluoromethylornithine in Subjects with Previous History of Skin Cancer

Howard H. Bailey, KyungMann Kim, Ajit Kumar Verma,

Cancer Prevention Research

2010

109

Human Biologic Response Modification by Interferon in the Absence of Measurable Serum Concentrations: A Comparative Trial of Subcutaneous and Intravenous Interferon-beta serine

Daniel A. Goldstein, Karen Sielaff, B. E. Stores,

JNCI Journal of the National Cancer Institute

1989

76

Phase I evaluation of a synthetic mutant of beta-interferon.

Michael Hawkins, Sandra J. Horning, Michael Konrad,

PubMed

1985

60

Phase II trial of interferon-β for treatment of recurrent glioblastoma multiforme

Thomas A. Duff, Ernest C. Borden, Janet W. Bay,

Journal of neurosurgery

1986

46

Modulation of 2′,5′-Oligoadenylate Synthetase in Patients Treated with Alpha-Interferon: Effects of Dose, Schedule, and Route of Administration

James A. Merritt, L. Andrew Ball, Karen Sielaff,

Journal of Interferon Research

1986

38

Phase I trial of human lymphoblastoid interferon with whole body hyperthermia in advanced cancer.

H. I. Robins, Karen Sielaff, B. Storer,

PubMed

1989

32

Clinical and Biological Effects of Recombinant Interferon-β Administered Intravenously Daily in Phase I Trial

ERNEST C. BORDEN, Michael Hawkins, Karen Sielaff,

Journal of Interferon Research

1988

32

Modulation of 2′,5′-OHgoadenylate Synthetase in Patients Treated with Alpha-Interferon: Effects of Dose, Schedule, and Route of Administration

James A. Merritt, L. Andrew Ball, Karen Sielaff,

Journal of Interferon Research

1992

24

Induced Proteins in Human Peripheral Mononuclear Cells Over a Range of Clinically Tolerable Doses of Interferon-γ

Donna M. Paulnock, Kathleen A. Havlin, BARRY M. STORER,

Journal of Interferon Research

1989

13

Page 1